Grant-to-Commercialization
Tracker
See innovation 18 months before patents. Track NIH SBIR, EIC Accelerator, NHLBI, and CIHR grants funding the next generation of EP technology.
18+ Month Head Start
Grants fund R&D 18-24 months before patent filings. See what's being developed before anyone else.
Commercialization Signals
SBIR Phase IIB requires investor commitment - a high-confidence signal of near-term commercial activity.
Funding Flow Tracking
Monitor who's getting funded and for what. Track emerging players before they hit your radar.
Commercialization Signal Detected
4 grants require investor/partner commitment
SBIR Phase IIB Bridge awards require matched investment - the highest confidence signal of near-term commercial activity.
Next-Generation Pulsed Field Ablation System with Real-Time Lesion Assessment
This Phase IIB SBIR Bridge Award supports the development of a novel pulsed field ablation system featuring real-time lesion assessment capabilities using integrated impedance mapping and AI-driven analysis. The system aims to reduce procedure time by 40% while improving first-pass isolation rates. Commercial partnership with strategic investor secured.
AI-Powered Cardiac Mapping for Complex Arrhythmia Substrate Identification
Development of machine learning algorithms for automated identification of arrhythmogenic substrates in complex ventricular tachycardia cases. The platform integrates with existing 3D mapping systems to provide real-time guidance during ablation procedures.
Miniaturized Leadless Dual-Chamber Pacing System
Revolutionary leadless pacing system enabling true dual-chamber functionality without leads. Proprietary communication protocol ensures reliable AV synchrony while maintaining battery longevity exceeding 10 years.
Wearable Continuous AF Detection and Stroke Risk Monitoring Platform
Development of a wearable patch-based system for continuous atrial fibrillation monitoring with integrated stroke risk assessment. Aims to improve AF detection sensitivity to 98% while reducing false positive rates.
Bioabsorbable Temporary Pacing Lead Technology
Investigation of novel bioabsorbable materials for temporary post-surgical pacing applications. The technology eliminates the need for lead removal procedures and associated complications.
Tissue-Selective Ablation Energy Delivery System
Development of a tissue-selective ablation system that can distinguish between cardiac tissue types, enabling precise lesion creation while sparing surrounding structures. Investor commitment from major EP device company secured.
Machine Learning for Personalized Anti-Arrhythmic Drug Selection
Development of machine learning algorithms to predict patient response to anti-arrhythmic medications based on genetic, clinical, and ECG features. Aims to improve first-line drug selection accuracy by 60%.
Catheter-Based Autonomic Modulation for AF Treatment
Investigation of catheter-based autonomic modulation as an adjunct to pulmonary vein isolation for persistent atrial fibrillation. Targets the intrinsic cardiac nervous system to reduce AF recurrence rates.
Digital Twin Technology for EP Procedure Planning
Development of patient-specific cardiac digital twins for pre-procedural planning and simulation of ablation strategies. Combines CT/MRI imaging with electrophysiological modeling.
Ultra-Low Power Implantable Cardiac Monitor
Development of ultra-low power implantable cardiac monitor with 15-year battery life using novel energy harvesting and ultra-efficient signal processing.
Free
- View last 10 grants
- Basic search
- Custom alerts
- Export data
Professional
- Full grant history
- Custom alerts
- Export to Excel
- Commercialization signals
Enterprise
- Everything in Professional
- API access
- Custom data feeds
- Dedicated support
Track These Companies on .ventures
Many grant recipients are early-stage companies seeking investment. Track them on our sister platform for deal flow and investment opportunities.